Company Overview of Dermira, Inc.
Key Executives for Dermira, Inc.
|Thomas G. Wiggans||148 Relationships||Co-Founder, Chairman and Chief Executive Officer||64|
|Eugene Andrew Bauer M.D.||69 Relationships||Co-Founder, Chief Medical Officer, Director and Member of Science & Technology Committee||74|
|Christopher M. Griffith||No Relationships||Co-Founder and Vice President of Corporate Development & Strategy||40|
|Andrew L. Guggenhime||5 Relationships||Chief Financial Officer and Chief Operating Officer||48|
|Christine R. Conroy Pharm. D.||No Relationships||Senior Vice President for Regulatory Affairs||55|
|View More Key Executives|
Dermira, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Thomas G. Wiggans||148 Relationships||Dermira, Inc.||64|
|Eugene Andrew Bauer M.D.||69 Relationships||Dermira, Inc.||74|
|Frederick B. Craves Ph.D.||137 Relationships||Bay City Capital LLC||70|
|Jake R. Nunn CFA||46 Relationships||New Enterprise Associates||46|
|David Eric Cohen M.D., M.P.H||50 Relationships||Dermira, Inc.||51|
Dermira, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Matthew K. Fust||42 Relationships||3 Executives|
|Compensation Committee Ph.D.||Frederick B. Craves||137 Relationships||2 Executives|
|Nominating Committee CFA||Jake R. Nunn||46 Relationships||3 Executives|
|Corporate Governance Committee CFA||Jake R. Nunn||46 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$465.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.